Gotowe bibliografie tematyczne / Respiratory Diseases / Artykuły w czasopismach

Artykuły w czasopismach na temat „Respiratory Diseases”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Respiratory Diseases.
Autor: Grafiati
Data publikacji: 4 czerwca 2021
Data aktualizacji: 1 czerwca 2024

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Respiratory Diseases”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Gianoutsos, Peter. "Respiratory diseases". Medical Journal of Australia 152, nr 2 (styczeń 1990): 102–3. http://dx.doi.org/10.5694/j.1326-5377.1990.tb124474.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

James, D. G., i O. M. Sharma. "Respiratory diseases." Postgraduate Medical Journal 66, nr 771 (1.01.1990): 1–15. http://dx.doi.org/10.1136/pgmj.66.771.1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

James, D. G. "Respiratory diseases." Postgraduate Medical Journal 68, nr 797 (1.03.1992): 160–73. http://dx.doi.org/10.1136/pgmj.68.797.160.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Frossard, Nelly. "Respiratory diseases". Drug Discovery Today: Disease Models 3, nr 3 (wrzesień 2006): 197–98. http://dx.doi.org/10.1016/j.ddmod.2006.10.003.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Suwabe, Akira. "1. Respiratory Diseases". Nihon Naika Gakkai Zasshi 97, nr 12 (2008): 2927–35. http://dx.doi.org/10.2169/naika.97.2927.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Tojo, Naoko. "2. Respiratory Diseases." Nihon Naika Gakkai Zasshi 100, nr 11 (2011): 3209–14. http://dx.doi.org/10.2169/naika.100.3209.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Ramsdale, Helen. "New Respiratory Diseases". Canadian Respiratory Journal 10, nr 3 (2003): 131–32. http://dx.doi.org/10.1155/2003/854839.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Beckett, William S. "Occupational Respiratory Diseases". New England Journal of Medicine 342, nr 6 (10.02.2000): 406–13. http://dx.doi.org/10.1056/nejm200002103420607.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Kilgore, David, i Wadie Najm. "Common Respiratory Diseases". Primary Care: Clinics in Office Practice 37, nr 2 (czerwiec 2010): 297–324. http://dx.doi.org/10.1016/j.pop.2010.02.007.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Merchant, James. "Agricultural Respiratory Diseases". Seminars in Respiratory and Critical Care Medicine 7, nr 03 (styczeń 1986): 211–24. http://dx.doi.org/10.1055/s-2007-1012617.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
11

Balmes, John R. "OCCUPATIONAL RESPIRATORY DISEASES". Primary Care: Clinics in Office Practice 27, nr 4 (grudzień 2000): 1009–37. http://dx.doi.org/10.1016/s0095-4543(05)70187-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
12

Moise, N. Sydney. "Viral Respiratory Diseases". Veterinary Clinics of North America: Small Animal Practice 15, nr 5 (wrzesień 1985): 919–28. http://dx.doi.org/10.1016/s0195-5616(85)50102-3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
13

Hoskins, Johnny D. "Feline Respiratory Diseases". Veterinary Clinics of North America: Small Animal Practice 29, nr 4 (lipiec 1999): 945–58. http://dx.doi.org/10.1016/s0195-5616(99)50083-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
14

Kendrick, Roger E. "Ferret Respiratory Diseases". Veterinary Clinics of North America: Exotic Animal Practice 3, nr 2 (maj 2000): 453–64. http://dx.doi.org/10.1016/s1094-9194(17)30081-6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
15

Nichols, Donald K. "Amphibian Respiratory Diseases". Veterinary Clinics of North America: Exotic Animal Practice 3, nr 2 (maj 2000): 551–54. http://dx.doi.org/10.1016/s1094-9194(17)30089-0.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
16

Holland, W. W. "Chronic respiratory diseases." Journal of Epidemiology & Community Health 47, nr 1 (1.02.1993): 4–5. http://dx.doi.org/10.1136/jech.47.1.4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
17

Maio, S., S. Baldacci, M. Borbotti, A. Angino, F. Martini, B. Piegaia, P. Silvi, M. Simoni, F. Di Pede i G. Viegi. "Respiratory allergic diseases". World Allergy Organization Journal &NA; (listopad 2007): S180. http://dx.doi.org/10.1097/01.wox.0000301833.17048.6f.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
18

Geltser, B. I., I. G. Kurpatov, A. A. Dej i A. G. Kozhanov. "Respiratory muscles dysfunction and respiratory diseases". Terapevticheskii arkhiv 91, nr 3 (15.03.2019): 93–100. http://dx.doi.org/10.26442/00403660.2019.03.000108.

Pełny tekst źródła
Streszczenie:
This review presents an analysis of the literature on the topic of respiratory muscle (RM) dysfunction in various forms of respiratory pathology: chronic obstructive pulmonary disease (COPD), asthma, community-acquired pneumonia, idiopathic pulmonary fibrosis (IPF), sarcoidosis and interstitial lung diseases (ILD), associated with systemic connective tissue diseases (polymyositis, dermatomyositis and systemic lupus erythematosus - SLE). Various clinical and pathophysiological aspects of RM dysfunction and general patterns of its pathogenesis were examined. It was proved that the role of RM in the development of respiratory failure depends on the form and stage of the pulmonary pathology and the severity of systemic manifestations of these diseases: excessive proteolysis, oxidative stress, hypoxia, chronic systemic inflammation. These factors modify the morphofunctional status of RM, worsens their contractile function, which is contributed to the development of respiratory failure. In some cases, the primary weakness of RM precedes the clinical manifestation of pulmonary pathology, which is distinctive for some variants of myositis-associated ILD and SLE. Endogenous intoxication syndrome plays a significant role in the development of RM dysfunction during community-acquired pneumonia. It is noted that sarcoid pulmonary ventilation disorders associate with the RM weakness, but not with the degree of lung damage. In most cases, secondary RM dysfunction predominates that contributes to respiratory failure progression, which is especially noticeable in case of COPD, asthma and IPF.
Style APA, Harvard, Vancouver, ISO itp.
19

Tatsumi, Koichiro. "Respiratory diseases as lifestyle-related diseases". Health Evaluation and Promotion 39, nr 6 (2012): 821–28. http://dx.doi.org/10.7143/jhep.39.821.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
20

Paramjyothi, G. "Respiratory Diseases and Coronary Artery Diseases". Indian Journal of Cardiovascular Disease in Women WINCARS 02, nr 01 (marzec 2017): 056–67. http://dx.doi.org/10.1055/s-0038-1656461.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
21

Cheberyachko, S., Yu Cheberyachko, D. Radchuk, O. Deryugin, D. Klimov, O. Sharovatova i V. Gridiaiev. "INDIVIDUAL RESPIRATORY PROTECTION EQUIPMENT: INNOVATIONS TO REDUCE THE RISK OF OCCUPATIONAL DISEASES". Municipal economy of cities 1, nr 175 (3.04.2023): 221–28. http://dx.doi.org/10.33042/2522-1809-2023-1-175-221-228.

Pełny tekst źródła
Streszczenie:
Individual respiratory protective equipment (PPE) is the last barrier to protect workers when performing production tasks in harmful and dangerous working conditions. The article analyzes modern innovative designs of personal respiratory protective equipment, which increase the level of protection of users during their operation. The method of morphological analysis is applied. This method based on the selection of possible solutions for assessing the manufacturability of PPE models (if there is a system of criteria) and making a rational decision regarding the features of their application in production conditions. As a result, it was established that in order to ensure the appropriate duration of the protective action of gas and dust filters and to avoid both poisoning of workers due to the ingress of harmful aerosols into the sub-mask space of the filter respirator, and excessive physical exhaustion due to the increase in pressure drop above the standard substances, it is recommended to equip the filters with special indicators for determining air pollution and pressure drop values. It was determined that in order to increase the reliability of the protection of workers, it is necessary to equip filter respirators with the functions of operational control of breathing resistance, place a headrest to control the occurrence of possible gaps behind the obturation band when performing various production operations, and establish the real term of the protective effect of the filters. The practical value of the work is innovative solutions to improve the designs of existing filter respirators, which will allow control over technological parameters during operation. In particular, the density along the obturation strip and the magnitude of the tension force of the respirator headgear. Recommendations are also given for controlling the term of the protective action of gas filters, since determining the specified indicators based on the organoleptic abilities of the user is dangerous for health. Keywords: risk, means of individual protection of respiratory organs, filtering respirator.
Style APA, Harvard, Vancouver, ISO itp.
22

Cheberiachko, S. I., O. O. Yavorska, A. V. Yavorskyi i M. Yu Ikonnikov. "A risk of pulmonary diseases in miners while using dust respirators". Naukovyi Visnyk Natsionalnoho Hirnychoho Universytetu, nr 5 (30.10.2022): 104–9. http://dx.doi.org/10.33271/nvngu/2022-5/104.

Pełny tekst źródła
Streszczenie:
Purpose. To determine magnitudes of the occupational risks of respiratory disease (pneumoconiosis) occurrence in miners while using filter respirators on the basis of an exposure dust dose with the consideration of work experience. Methodology. To assess occupational risks, a new approach proposed by the Research Institute of Complex Hygiene and Occupational Diseases is used. The approach is based on determining an exposure dose of a hazardous substance entering the workers lungs during their professional contact with it taking into account the volume of pulmonary ventilation, the number of shifts, and work experience. Findings. Use of dust respirators reduces the risk of occupational respiratory diseases but does not eliminate it completely. It has been established that with more than three-year work experience and coal dust concentrations of more than 50 mg/m3, use of dust filter respirators does not ensure a minimal degree of the occupational disease risks. At the same time, it has been identified that if work experience is less than 3 years with the use of filter respirators, the risk of occupational diseases will be minimal. It has been proved that the risk assessment should involve using the minimal value of a protection factor of a respirator, which is fixed in the production environment. It has been shown that working within the areas with dust concentrations higher than 100 mg/m3 is dangerous for miners; over time, with the accumulation of sufficient dust in the lungs it will lead to the development of silicosis. Originality. It consists in scientific substantiation of the magnitude of occupational risk of respiratory diseases in miners, taking into account a real protection factor of respirators, which is determined at the workplace based on the calculation of an exposure dose and time of professional contact with hazardous substances. Practical value. The experience of safe operation in mine workings with and without using filter respirators has been substantiated, basing on a safe value of coal dust concentration, at which a low level of occupational risk of respiratory diseases is recorded. Recommendations for determining the dust load taking into account a protection factor of respirators at the workplace have been developed.
Style APA, Harvard, Vancouver, ISO itp.
23

Arif, Shahrukh, i Margaret A. Pisani. "Aging and Respiratory Diseases". US Respiratory & Pulmonary Diseases 5, nr 1 (2020): 33. http://dx.doi.org/10.17925/usprd.2020.5.1.33.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
24

Bakulin, I. G., O. Yu Chizhova, L. N. Belousova, E. Yu Pavlova, A. G. Sushilova, A. D. Sheiko i M. K. Alieva. "Respiratory Diseases and Hyperammoniemia". Doctor.Ru 19, nr 11 (2020): 32–37. http://dx.doi.org/10.31550/1727-2378-2020-19-11-32-37.

Pełny tekst źródła
Streszczenie:
Study Objective: To assess the incidence of hyperammoniemia in respiratory diseases. Materials and Methods. 36 patients with respiratory diseases took part in the study: chronic obstructive pulmonary disease (COPD) (21 (58.3%) patients), chronic bronchitis (5 (13.9%) patients), and pneumonia (10 (27.8%) patients). Mean age was 66.8 ± 11.8 years; 9 (25.0%) females and 27 (75.0%) males. Each patient had his/her capillary ammonia measured (microdiffusion). In order to assess the nutrition status, all patients had their primary somatometry measured: height, weight, body mass index, inactive arm circumference, waist circumference, skin-fat rolls thickness under biceps, above triceps, below shoulder blade angle, in inguinal region. Study Results. 9 (25.0%) out of 36 patients had hyperammoniemia (capillary ammonia level: 74.0 ± 7.1 nmol/L); their mean age was 62.3 ± 18.2 years. Patients with COPD/chronic bronchitis had significantly higher ammonia concentration (60.7 ± 16.6 mol/L) vs. patients with pneumonia (48.4 ± 14.3 mol/L; t = 2.2, p < 0.03). COPD patients demonstrated significant differences in ammonia levels depending on duration of disease. In the group of higher ammonia concentration, COPD lasted significantly longer (t = 4.03 p = 0.001). We did not find any sound correlation between nutritional (trophological) status and ammonia concentrations in patients with respiratory diseases (t < 2, p > 0.05). Conclusion. In 25% of cases, respiratory diseases were associated with hyperammoniemia that is non-cirrhotic, because hepatobiliary disorders in this group of patients were an exclusion criterion. Although no statistically significant correlation between non-cirrhotic hyperammoniemia and nutritional (trophological) status was demonstrated, pathogenic relations between them cannot be ruled out. Whether underweight is a determining factor in non-cirrhotic hyperammoniemia is still unclear and requires further research and more observations. Keywords: ammonia, non-cirrhotic hyperammoniemia, nutritional (trophological) status, respiratory diseases.
Style APA, Harvard, Vancouver, ISO itp.
25

Białek-Gosk, Katarzyna. "Guaifenesin in respiratory diseases". Medycyna Faktów 13, nr 1 (31.03.2020): 82–86. http://dx.doi.org/10.24292/01.mf.0120.9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
26

Raghu, Srikanti, i SuryaKiran Pulivarthi. "Respiratory diseases in pregnancy". Journal of Clinical and Scientific Research 4, nr 2 (2015): 149. http://dx.doi.org/10.15380/2277-5706.jcsr.14.048.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
27

Gałuszka, Aleksandra. "Physiotherapy for respiratory diseases". Journal of Education, Health and Sport 12, nr 8 (24.08.2022): 1002–11. http://dx.doi.org/10.12775/jehs.2022.12.08.084.

Pełny tekst źródła
Streszczenie:
The respiratory system is crucial to human life. Its performance determines the quality of life. Physical training helps patients suffering from various diseases of this system to build up physical fitness, improve breathing mechanics and reduce clumsy secretion in the bronchial tree. The right choice of techniques for working with such a patient is important. They use fitness training, strength training, breathing exercises, bronchial tree cleansing. Always consider possible contraindications
Style APA, Harvard, Vancouver, ISO itp.
28

Comolli, Jessica R., i Stephen J. Divers. "Respiratory Diseases of Snakes". Veterinary Clinics of North America: Exotic Animal Practice 24, nr 2 (maj 2021): 321–40. http://dx.doi.org/10.1016/j.cvex.2021.01.003.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
29

Mahajan, Vineet, i Jatinder Singh. "Prevention of Respiratory Diseases". International Journal of Medical and Dental Sciences 4, nr 1 (1.01.2015): 721. http://dx.doi.org/10.19056/ijmdsjssmes/2015/v4i1/79968.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
30

INOUE, HIROSHI. "Respiratory diseases and NO." Nihon Naika Gakkai Zasshi 86, nr 9 (1997): 1795–99. http://dx.doi.org/10.2169/naika.86.1795.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
31

DiMauro, Salvatore, i Eric A. Schon. "Mitochondrial Respiratory-Chain Diseases". New England Journal of Medicine 348, nr 26 (26.06.2003): 2656–68. http://dx.doi.org/10.1056/nejmra022567.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
32

Benato, Livia. "Respiratory diseases in rats". Companion Animal 17, nr 4 (maj 2012): 47–50. http://dx.doi.org/10.1111/j.2044-3862.2012.00163.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
33

Cockcroft, A. "Prevention of Respiratory Diseases". Occupational and Environmental Medicine 52, nr 6 (1.06.1995): 432. http://dx.doi.org/10.1136/oem.52.6.432.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
34

Kumar, RVijai. "Breathlessness & respiratory diseases". Lung India 23, nr 1 (2006): 34. http://dx.doi.org/10.4103/0970-2113.44428.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
35

Rupani, Hitasha, Tilman Sanchez-Elsner i Peter Howarth. "MicroRNAs and respiratory diseases". European Respiratory Journal 41, nr 3 (12.07.2012): 695–705. http://dx.doi.org/10.1183/09031936.00212011.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
36

Murugan, AT, i G. Sharma. "Obesity and respiratory diseases". Chronic Respiratory Disease 5, nr 4 (listopad 2008): 233–42. http://dx.doi.org/10.1177/1479972308096978.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
37

Dagan, Ron, i Philippe Lepage. "Introduction: Childhood Respiratory Diseases". Pediatric Infectious Disease Journal 28 (październik 2009): S119—S120. http://dx.doi.org/10.1097/inf.0b013e3181b6d7d5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
38

Nohynek, Hanna, Shabir Madhi i Carlos G. Grijalva. "Childhood Bacterial Respiratory Diseases". Pediatric Infectious Disease Journal 28 (październik 2009): S127—S132. http://dx.doi.org/10.1097/inf.0b013e3181b6d800.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
39

Dobler, Claudia C. "Biomarkers in respiratory diseases". Breathe 15, nr 4 (grudzień 2019): 265–66. http://dx.doi.org/10.1183/20734735.0329-2019.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
40

Miller, Robert. "HIV-associated respiratory diseases". Lancet 348, nr 9023 (sierpień 1996): 307–12. http://dx.doi.org/10.1016/s0140-6736(95)11037-2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
41

Rabe, Klaus F. "Understanding chronic respiratory diseases". Lancet 372, nr 9643 (wrzesień 2008): 1027–28. http://dx.doi.org/10.1016/s0140-6736(08)61426-9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
42

Schumacher, Juergen. "Respiratory diseases of reptiles". Seminars in Avian and Exotic Pet Medicine 6, nr 4 (październik 1997): 209–15. http://dx.doi.org/10.1016/s1055-937x(97)80007-2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
43

Zandbergen, J., H. Pols, M. Bright, C. De Loof i E. Griez. "Respiratory diseases in panic". Biological Psychology 31, nr 3 (grudzień 1990): 283. http://dx.doi.org/10.1016/0301-0511(90)90057-4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
44

Pison, Ulrich, Tobias Welte, Michael Giersig i David A. Groneberg. "Nanomedicine for respiratory diseases". European Journal of Pharmacology 533, nr 1-3 (marzec 2006): 341–50. http://dx.doi.org/10.1016/j.ejphar.2005.12.068.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
45

Witkowska, Anna, Marta Wiszniewska i Jolanta Walusiak-Skorupa. "Rare occupational respiratory diseases". Medycyna Pracy 71, nr 1 (20.01.2020): 89–104. http://dx.doi.org/10.13075/mp.5893.00895.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
46

Deeb, Barbara J., i Ronald E. DiGiacomo. "Respiratory Diseases of Rabbits". Veterinary Clinics of North America: Exotic Animal Practice 3, nr 2 (maj 2000): 465–80. http://dx.doi.org/10.1016/s1094-9194(17)30082-8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
47

Schoeb, Trenton R. "Respiratory Diseases of Rodents". Veterinary Clinics of North America: Exotic Animal Practice 3, nr 2 (maj 2000): 481–96. http://dx.doi.org/10.1016/s1094-9194(17)30083-x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
48

de Benedictis, Fernando Maria, Roberto Guidi, Silvia Carraro i Eugenio Baraldi. "Endpoints in respiratory diseases". European Journal of Clinical Pharmacology 67, S1 (23.11.2010): 49–59. http://dx.doi.org/10.1007/s00228-010-0922-2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
49

Ebihara, Satoru, Ikuko Okuni, Midori Miyagi i Hideaki Izukura. "Rehabilitation for Respiratory Diseases". Japanese Journal of Rehabilitation Medicine 53, nr 11 (2016): 829–33. http://dx.doi.org/10.2490/jjrmc.53.829.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
50

Prakash, Udaya B. S. "Respiratory Diseases in Rwanda". Chest 108, nr 1 (lipiec 1995): 5–7. http://dx.doi.org/10.1378/chest.108.1.5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany bibliografiami na temat „Respiratory Diseases” dla innych typów źródeł:
Rozprawy doktorskie Książki
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii